Back to 
Danske Bank A/S
Danske Bank A/S
ARQT
3 quarters
Position history for Danske Bank A/S's holdings in Arcutis Biotherapeutics, Inc.
No. Danske Bank exited its ARQT (Arcutis Biotherapeutics) position in Q3 2024. Its Q2 2024 13F listed 606 shares worth $5,636. Danske Bank already held ARQT in its Q1 2024 13F, the earliest on record, and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$6,005
Total Shares Change
-606
Quarter-by-Quarter History
Other major holders of ARQT: BlackRock, Inc., Jennison Associates LLC, FMR LLC